Cited by 7

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Retinal Photoreceptor Protection in an AMD-Related Mouse Model by Selective Sigma-1 or Sigma-2 Receptor Modulation

Mavlyutov, Timur A., Li, Jing, Liu, Xinying, Shen, Hongtao, Yang, Huan, McCurdy, Christopher R., Pattnaik, Bikash, Guo, Lian-Wang·2022·Genes

Abstract

The structurally and genetically distinct sigma-1 receptor (S1R) and sigma-2 receptor (S2R) comprise a unique class of drug binding sites. Their alleles are associated with human diseases involving neuronal systems, such as age-related macular degeneration (AMD) characterized by photoreceptor and retinal pigment epithelium (RPE) atrophy. Previous studies have suggested neuroprotective benefits for the brain and retina from pharmacological modulation of S1R and/or S2R. However, the effect of such modulation on AMD pathology remains underexplored. Here, we evaluated S1R- or S2R-selective modulation in an AMD-related model of Abca4−/−Rdh8−/− mice with a disrupted visual cycle that predisposes RPE and photoreceptors to illumination-induced damage. For S1R modulation, we used (+)-pentazocine, which is a high-affinity S1R-selective drug. For S2R modulation, we chose CM398, a high-affinity and highly S2R-selective ligand with drug-like properties. Abca4−/−Rdh8−/− mice received a single i.p. injection of (+)-pentazocine or CM398 or vehicle 30 min before illumination. Pretreatment with (+)-pentazocine improved electroretinogram a- and b-waves compared to that with vehicle. Consistently, in another AMD-related mouse model induced by tail-vein injected NaIO3, S1R genetic ablation aggravated photoreceptor loss. In Abca4−/−Rdh8−/− mice, pretreatment with CM398 appeared to partially avert illumination-induced photoreceptor loss and autofluorescent granule formation that signals RPE damage, as revealed by optical coherence tomography. Thus, this study using AMD-related models provides evidence of photoreceptor protection afforded by selective modulation of S1R or S2R.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/genes13122386

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • S2R expression is elevated in retinal pigment epithelium-specific Clic4 knockout mice, which exhibit functional and pathological hallmarks of dry AMD; TMEM97 knockout mice have exhibited conflicting results in dry AMD models; and S2R-selective modulation with CM398 reduced photoreceptor loss and retinal autofluorescent granules in an illumination-induced AMD model.

    “S2R expression is elevated in retinal pigment epithelium-specific Clic4 knockout mice, which exhibit both functional and pathological hallmarks of dry AMD. Conversely, TMEM97 knockout mice have exhibited conflicting results in dry AMD models, which are likely dependent upon the type of stressor used to induce pathology. Intravenous administration of sodium iodate to TMEM97 knockout animals induced”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Martin, 1976, The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197, 517
  2. Su, 1988, Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems, Science, 240, 219, 10.1126/science.2832949 · DOI
  3. Hellewell, 1990, A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain, Brain Res., 527, 244, 10.1016/0006-8993(90)91143-5 · DOI · Paper page
  4. Hanner, 1996, Purification, molecular cloning, and expression of the mammalian sigma1-binding site, Proc. Natl. Acad. Sci. USA, 93, 8072, 10.1073/pnas.93.15.8072 · DOI
  5. Alon, 2017, Identification of the gene that codes for the sigma2 receptor, Proc. Natl. Acad. Sci. USA, 114, 7160, 10.1073/pnas.1705154114 · DOI · Paper page
  6. Matsumoto, 2014, Sigma (sigma) receptors as potential therapeutic targets to mitigate psychostimulant effects, Adv. Pharmacol., 69, 323, 10.1016/B978-0-12-420118-7.00009-3 · DOI
  7. Schmidt, 2019, The Molecular Function of sigma Receptors: Past, Present, and Future, Trends Pharmacol. Sci., 40, 636, 10.1016/j.tips.2019.07.006 · DOI · Paper page
  8. Schmidt, 2018, Structural basis for sigma1 receptor ligand recognition, Nat. Struct. Mol. Biol., 25, 981, 10.1038/s41594-018-0137-2 · DOI
  9. Izzo, N.J., Colom-Cadena, M., Riad, A.A., Xu, J., Singh, M., Abate, C., Cahill, M.A., Spires-Jones, T.L., Bowen, W.D., and Mach, R.H. (2020). Proceedings from the Fourth International Symposium on sigma-2 Receptors: Role in Health and Disease. eNeuro, 7. · DOI
  10. Bohlega, 2011, A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis, Ann. Neurol., 70, 913, 10.1002/ana.22534 · DOI
  11. Fritsche, 2016, A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants, Nat. Genet., 48, 134, 10.1038/ng.3448 · DOI · Paper page
  12. Smith, 2018, Sigma 1 receptor: A novel therapeutic target in retinal disease, Prog. Retin. Eye Res., 67, 130, 10.1016/j.preteyeres.2018.07.003 · DOI
  13. Xu, Z., Lei, Y., Qin, H., Zhang, S., Li, P., and Yao, K. (2022). Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms. Int. J. Mol. Sci., 23. · DOI
  14. Shen, 2021, TMEM97 ablation aggravates oxidant-induced retinal degeneration, Cell. Signal., 86, 110078, 10.1016/j.cellsig.2021.110078 · DOI · Paper page
  15. Jin, 2022, Neuroprotective Effects of sigma2R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington’s Disease, ACS Chem. Neurosci., 13, 2852, 10.1021/acschemneuro.2c00274 · DOI · Paper page
  16. Martin, 2022, Bridging Known and Unknown Unknowns: From Natural Products and Their Mimics to Unmet Needs in Neuroscience, Acc. Chem. Res., 55, 2397, 10.1021/acs.accounts.1c00773 · DOI
  17. Mavlyutov, 2017, Peeking into Sigma-1 Receptor Functions Through the Retina, Adv. Exp. Med. Biol., 964, 285, 10.1007/978-3-319-50174-1_19 · DOI
  18. Smith, 2008, In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine, Investig. Ophthalmol. Vis. Sci., 49, 4154, 10.1167/iovs.08-1824 · DOI
  19. Wang, 2016, Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration, Proc. Natl. Acad. Sci. USA, 113, E3764
  20. Wang, 2020, Comparison of Sigma 1 Receptor Ligands SA4503 and PRE084 to (+)-Pentazocine in the rd10 Mouse Model of RP, Investig. Ophthalmol. Vis. Sci., 61, 3, 10.1167/iovs.61.13.3 · DOI
  21. Wang, 2016, Role of Sigma 1 Receptor in Retinal Degeneration of the Ins2Akita/+ Murine Model of Diabetic Retinopathy, Investig. Ophthalmol. Vis. Sci., 57, 2770, 10.1167/iovs.15-18995 · DOI
  22. Klimanskaya, 2006, Retinal pigment epithelium, Methods Enzymol., 418, 169, 10.1016/S0076-6879(06)18011-8 · DOI
  23. Datta, 2017, The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD, Prog. Retin. Eye Res., 60, 201, 10.1016/j.preteyeres.2017.03.002 · DOI
  24. Maeda, 2008, Retinopathy in mice induced by disrupted all-trans-retinal clearance, J. Biol. Chem., 283, 26684, 10.1074/jbc.M804505200 · DOI · Paper page
  25. Maeda, 2009, Evaluation of potential therapies for a mouse model of human age-related macular degeneration caused by delayed all-trans-retinal clearance, Investig. Ophthalmol. Vis. Sci., 50, 4917, 10.1167/iovs.09-3581 · DOI
  26. Gao, 2021, Functional regulation of an outer retina hyporeflective band on optical coherence tomography images, Sci. Rep., 11, 10260, 10.1038/s41598-021-89599-1 · DOI
  27. Li, J., Felix-Soriano, E., Wright, K.R., Shen, H., Baer, L.A., Stanford, K.I., and Guo, L.W. (2022). Differential Responses to Sigma-1 or Sigma-2 Receptor Ablation in Adiposity, Fat Oxidation, and Sexual Dimorphism. Int. J. Mol. Sci., 23. · DOI
  28. Franco, 2009, Decreased visual function after patchy loss of retinal pigment epithelium induced by low-dose sodium iodate, Investig. Ophthalmol. Vis. Sci., 50, 4004, 10.1167/iovs.08-2898 · DOI
  29. Chu, 2015, The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes, EBioMedicine, 2, 1806, 10.1016/j.ebiom.2015.10.017 · DOI · Paper page
  30. Intagliata, 2020, Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]im idazol-2(3H)-one (CM398), with Drug-like Properties and Antinociceptive Effects In Vivo, AAPS J., 22, 94, 10.1208/s12248-020-00472-x · DOI
  31. Rishton, 2021, Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease, ACS Med. Chem. Lett., 12, 1389, 10.1021/acsmedchemlett.1c00048 · DOI
  32. Kohno, 2014, CCL3 production by microglial cells modulates disease severity in murine models of retinal degeneration, J. Immunol., 192, 3816, 10.4049/jimmunol.1301738 · DOI
  33. Wang, 2021, Optimal timing for activation of sigma 1 receptor in the Pde6b(rd10)/J (rd10) mouse model of retinitis pigmentosa, Exp. Eye Res., 202, 108397, 10.1016/j.exer.2020.108397 · DOI
  34. Chen, 2013, Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration, J. Clin. Investig., 123, 5119, 10.1172/JCI69076 · DOI
  35. Fontaine, 2020, Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal models of age-related macular degeneration and Stargardt disease, Aging, 12, 6151, 10.18632/aging.103014 · DOI
  36. Taubitz, 2018, Ultrastructural alterations in the retinal pigment epithelium and photoreceptors of a Stargardt patient and three Stargardt mouse models: Indication for the central role of RPE melanin in oxidative stress, PeerJ, 6, e5215, 10.7717/peerj.5215 · DOI
  37. Shimazawa, 2015, Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage, Exp. Eye Res., 132, 64, 10.1016/j.exer.2015.01.017 · DOI
  38. Baek, 2021, KRT8 (keratin 8) attenuates necrotic cell death by facilitating mitochondrial fission-mediated mitophagy through interaction with PLEC (plectin), Autophagy, 17, 3939, 10.1080/15548627.2021.1897962 · DOI
  39. Abatematteo, F.S., Niso, M., Lacivita, E., and Abate, C. (2021). sigma2 Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach. Molecules, 26. · DOI
  40. Maeda, 2014, Two-photon microscopy reveals early rod photoreceptor cell damage in light-exposed mutant mice, Proc. Natl. Acad. Sci. USA, 111, E1428, 10.1073/pnas.1317986111 · DOI
  41. Bucolo, 2006, Sigma receptor ligands protect human retinal cells against oxidative stress, Neuroreport, 17, 287, 10.1097/01.wnr.0000199469.21734.e1 · DOI
  42. Shen, 2021, BRD2 regulation of sigma-2 receptor upon cholesterol deprivation, Life Sci. Alliance, 4, e201900540, 10.26508/lsa.201900540 · DOI
  43. Oyer, 2019, Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes, Front. Pharmacol., 10, 1141, 10.3389/fphar.2019.01141 · DOI
  44. Wilson, L.L., Alleyne, A.R., Eans, S.O., Cirino, T.J., Stacy, H.M., Mottinelli, M., Intagliata, S., McCurdy, C.R., and McLaughlin, J.P. (2022). Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain. Molecules, 27. · DOI
  45. Zeng, 2014, Functional assays to define agonists and antagonists of the sigma-2 receptor, Anal. Biochem., 448, 68, 10.1016/j.ab.2013.12.008 · DOI
  46. Yang, K., Zeng, C., Wang, C., Sun, M., Yin, D., and Sun, T. (2020). Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer’s Disease Treatment via Its Regulation of Cholesterol Homeostasis. Molecules, 25. · DOI
  47. Zhu, 2021, Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer, Cell Death Dis., 12, 912, 10.1038/s41419-021-04211-8 · DOI
  48. Zeng, 2019, TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death, Cell Death Discov., 5, 58, 10.1038/s41420-019-0141-2 · DOI · Paper page
  49. Sahn, 2017, Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice, ACS Chem. Neurosci., 8, 1801, 10.1021/acschemneuro.7b00200 · DOI
  50. Merlos, 2020, The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception, Mol. Brain, 13, 150, 10.1186/s13041-020-00676-4 · DOI
  51. Chan, 2020, Vigabatrin-Induced Retinal Functional Alterations and Second-Order Neuron Plasticity in C57BL/6J Mice, Investig. Ophthalmol. Vis. Sci., 61, 17, 10.1167/iovs.61.2.17 · DOI
  52. Yang, 2017, Role of the sigma-1 receptor chaperone in rod and cone photoreceptor degenerations in a mouse model of retinitis pigmentosa, Mol. Neurodegener., 12, 68, 10.1186/s13024-017-0202-z · DOI
  53. Upadhyay, 2020, Oxidative stress in the retina and retinal pigment epithelium (RPE): Role of aging, and DJ-1, Redox Biol., 37, 101623, 10.1016/j.redox.2020.101623 · DOI
  54. McLellan, 2012, Optical coherence tomography for the evaluation of retinal and optic nerve morphology in animal subjects: Practical considerations, Vet. Ophthalmol., 15, 13, 10.1111/j.1463-5224.2012.01045.x · DOI
  55. Mavlyutov, 2017, APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum, Oncotarget, 8, 51317, 10.18632/oncotarget.17906 · DOI

Cited by

Sorted by citations

Metadata

Authors
Mavlyutov, T. A., Li, J., Liu, X., Shen, H., Yang, H., McCurdy, C. R., Pattnaik, B., & Guo, L.-W.
Affiliations
  • Department of Surgery, University of Wisconsin, Madison, WI 53705, USA
  • Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA
  • Department of Pediatrics, University of Wisconsin, Madison, WI 53705, USA
  • Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA
Venue
Genes
Publisher
MDPI AG
Published
2022-12-16
Volume
13
Issue
12
Pages
2386
ISSN
2073-4425
Cited by
7
References
4
Language
en
Funders
  • NEI (EY022678, EY029809, P30EY016665)
  • the RRF-Rebecca Meyer Brown Professorship of McPherson Eye Research Institute (EY022678, EY029809, P30EY016665)
  • University of Wisconsin-Madison Vision Core (EY022678, EY029809, P30EY016665)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review